TY - JOUR
T1 - Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome
AU - Wang, Jian
AU - Ayano, Eri
AU - Maitani, Yoshie
AU - Kanazawa, Hideko
N1 - Funding Information:
We thank Dr. Megumi Tago (Keio University, Tokyo, Japan) for providing plasmid DNA used in this study, and Dr. Yoshiyuki Hattori (Hoshi University, Tokyo, Japan) for his helpful comments in this study. This study was supported by a Grant-in-Aid for Exploratory Research (Grant no. 25670081) from the Japan Society for the Promotion of Science (JSPS), Japan.
Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/5/15
Y1 - 2017/5/15
N2 - Short interfering RNA (siRNA) delivery systems using nanoparticle carriers have been limited by inefficient intracellular delivery. One drawback is the poor cellular uptake of siRNA/particle complexes through the plasma membrane and release of the nucleic acids into the cytosol. In this study, to develop the temperature-responsive liposome as a novel carrier for siRNA delivery, we prepared lipoplexes and assessed cellular uptake of siRNA and gene silencing activity of target genes, compared with those of a commercial transfection reagent, Lipofectamine RNAiMAX, and non-modified or PEGylated liposomes. The temperature-responsive polymer, N-isopropylacrylamide-co-N,N’-dimethylaminopropylacrylamide [P(NIPAAm-co-DMAPAAm)]-modified liposome induced faster intracellular delivery because P(NIPAAm-co-DMAPAAm) exhibits a lower critical solution temperature (LCST) changing its nature from hydrophilic to hydrophobic above the LCST. The temperature-responsive liposomes showed significantly higher gene silencing activity than other carriers with less cytotoxicity. Furthermore, we showed that the temperature-responsive lipoplexes were internalized mainly via microtubule-dependent transport and also by the clathrin-mediated endocytosis pathway. This is the first report that temperature-responsive polymer-modified liposomes thermally enhanced silencing activity of siRNA. The dehydrated polymer on the liposomes, and its aggregation caused around the LCST, can probably be attributed to effective cellular uptake of the lipoplexes for gene silencing activity by interaction with the cell membrane.
AB - Short interfering RNA (siRNA) delivery systems using nanoparticle carriers have been limited by inefficient intracellular delivery. One drawback is the poor cellular uptake of siRNA/particle complexes through the plasma membrane and release of the nucleic acids into the cytosol. In this study, to develop the temperature-responsive liposome as a novel carrier for siRNA delivery, we prepared lipoplexes and assessed cellular uptake of siRNA and gene silencing activity of target genes, compared with those of a commercial transfection reagent, Lipofectamine RNAiMAX, and non-modified or PEGylated liposomes. The temperature-responsive polymer, N-isopropylacrylamide-co-N,N’-dimethylaminopropylacrylamide [P(NIPAAm-co-DMAPAAm)]-modified liposome induced faster intracellular delivery because P(NIPAAm-co-DMAPAAm) exhibits a lower critical solution temperature (LCST) changing its nature from hydrophilic to hydrophobic above the LCST. The temperature-responsive liposomes showed significantly higher gene silencing activity than other carriers with less cytotoxicity. Furthermore, we showed that the temperature-responsive lipoplexes were internalized mainly via microtubule-dependent transport and also by the clathrin-mediated endocytosis pathway. This is the first report that temperature-responsive polymer-modified liposomes thermally enhanced silencing activity of siRNA. The dehydrated polymer on the liposomes, and its aggregation caused around the LCST, can probably be attributed to effective cellular uptake of the lipoplexes for gene silencing activity by interaction with the cell membrane.
KW - Cationic liposome
KW - Cellular uptake
KW - Gene silencing
KW - NIPAAm
KW - siRNA delivery temperature-responsive liposome
UR - http://www.scopus.com/inward/record.url?scp=85016144988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016144988&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2017.03.035
DO - 10.1016/j.ijpharm.2017.03.035
M3 - Article
C2 - 28330734
AN - SCOPUS:85016144988
SN - 0378-5173
VL - 523
SP - 217
EP - 228
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1
ER -